Neuroscience

Articles and news from the latest research reports.

73 notes

Ultrasound device combined with clot-buster safe for stroke

A study led by researchers at The University of Texas Health Science Center at Houston (UTHealth) showed that a hands-free ultrasound device combined with a clot-busting drug was safe for ischemic stroke patients.

image

The results of the phase II pilot study were reported today in the American Heart Association journal Stroke. Lead author is Andrew D. Barreto, M.D., assistant professor of neurology in the Stroke Program at the UTHealth Medical School. Principal investigator is James C. Grotta, M.D., professor and chair of the Department of Neurology at the UTHealth Medical School, the Roy M. & Phyllis Gough Huffington Distinguished Chair and co-director of the Mischer Neuroscience Institute at Memorial Hermann-Texas Medical Center.

The device, which uses UTHealth technology licensed to Cerevast Therapeutics, Inc., is placed on the stroke patient’s head and delivers ultrasound to enhance the effectiveness of the clot-busting drug tissue plasminogen activator (tPA). Unlike the traditional hand-held ultrasound probe that’s aimed at a blood clot, the hands-free device used 18 separate probes and showers the deep areas of the brain where large blood clots cause severe strokes. 

“Our goal is to open up more arteries in the brain and help stroke patients recover,” said Barreto, an attending physician at Mischer Neuroscience Institute. “This technology would have a significant impact on patients, families and society if we could improve outcomes by another 10 percent or more by adding ultrasound to patients who’ve already received tPA.”

In the first study of its kind, 20 moderately severe ischemic stroke patients (12 men and eight women, average age 63 years) received intravenous tPA up to 4.5 hours after symptoms occurred and two hours exposure to 2-MHz pulsed wave transcranial ultrasound.

Researchers reported that 13 (or 65 percent) patients either returned home or to rehabilitation 90 days after the combination treatment. After three months, five of the 20 patients had no disability from the stroke and one had slight disability.

(Source: uthouston.edu)

Filed under stroke ultrasound device tissue plasminogen activator clotbust neuroscience science

  1. dourque reblogged this from fossilzed-tree
  2. idlnmclean reblogged this from neurosciencestuff
  3. deemmzee reblogged this from neurosciencestuff
  4. celestialmedicine reblogged this from 666hashslingingslasher666
  5. 666hashslingingslasher666 reblogged this from neurosciencestuff
  6. emilyrose620 reblogged this from neurosciencestuff
  7. hospitalsanjavier reblogged this from neurosciencestuff
  8. braindude reblogged this from neurosciencestuff and added:
    Cool!
  9. brainimmune reblogged this from neurosciencestuff
  10. mc-reg reblogged this from neurosciencestuff
  11. forrest-e reblogged this from neurosciencestuff
  12. oliveyouidoxiii reblogged this from neurosciencestuff
  13. holy-shit-8 reblogged this from neurosciencestuff
  14. punkrockdanny reblogged this from neurosciencestuff
  15. notaweaponspecialist reblogged this from heartoftardis
  16. heartoftardis reblogged this from neurosciencestuff
  17. zoyawashere reblogged this from neurosciencestuff and added:
    This is amazing.
  18. thecrunkstables reblogged this from neurosciencestuff
  19. cpnfabulous reblogged this from neurosciencestuff
  20. sconic-screwdriver reblogged this from neurosciencestuff
  21. star-stars reblogged this from neurosciencestuff
free counters